Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2005-11-02
2008-10-07
Mosher, Mary R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C436S523000, C436S526000, C436S527000, C436S528000, C436S533000, C436S518000, C435S005000, C435S007100, C435S007220, C435S007930
Reexamination Certificate
active
07432046
ABSTRACT:
The present invention relates to methods of determining anti-infectious agent IgG avidity, for example, human anti-cytomegalovirus and human anti-toxoplasma IgG avidity, using a competitive assay format.
REFERENCES:
patent: 5705330 (1998-01-01), Shah et al.
patent: 6074817 (2000-06-01), Landini et al.
patent: 6329157 (2001-12-01), Maine et al.
patent: 6372426 (2002-04-01), Zens
patent: 7094879 (2006-08-01), Maine et al.
patent: 0 431 541 (1990-04-01), None
patent: 0 751 147 (1990-04-01), None
Makarananda, et al. Competitive ELISA. In: Methods in Molecular Biology, vol. 80: Immunochemical Protocols, 2nded. Edited by: J.D. Pound. © 1998, Humana Pres Inc., Totowa, NJ. p. 155-160.
Sager, et al. Immunodiagnosis of primary Toxoplasma gondii infection in sheep by the use of a p30 IgG ELISA. Parasitol Res (2003) 91:171-174.
Just-Nubling, et al. Primary cytomegalovirus infection in an outpatient setting—laboratory markers and clinical aspects. Infection (Germany) Oct. 2003, 31 (5) p. 318-23.
Abou-Basha, L.M., et al., “Specific IgG avidity in acute and chronic human fascioliasis”,East. Mediterr. Health J., 6:919-925 (2000).
Baccard-Longere, M., et al., “Multicenter Evaluation of a rapid and Convenient Mehtod for Determination of Cytomegalovirus Immunoglobulin G Avidity”,Clin.&Diag. Lab. Immun., 8(2):429-431 (2001).
Benjamin, P.A., et al., “Increased titre and avidity of IgG antibodies toPorphyromonas gingivaliswhole cells and a cell surface protein in subjects with adult periodontitis”,J. Period.. Res., 32:31-39 (1997).
Bodeus, M., et al., “Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women”,Clin, And Diag. Virol., 9:9-16 (1998).
Bonhomme, A., et al., “Quantitative Immunolocalization of a P29 Protein (GRA7), a New Antigen of Toxoplasma gondii”,J. of Histochem.&Cytochem., 46(12):1411-1421 (1998).
Boppana, S.B., et al., “Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality”,Pediatr. Infect. Dis. J., 11(2):93-99 (1992).
Boppana, S.B., et al., “Symptomatic Congenital Cytomegalovirus Infection in Infants Born to Mothers With Preexisting Immunity to Cytomegalovirus”,Pediatrics, 104:55-60 (1999).
Britt, W.J. & Alford, C.A., “Cytomegalovirus”,Cytomegalovirus, In Fields Virology, 3rdEd., Chapt. 77:2493-2523 (1996).
Burg, J.L., et al., Molecular Analysis of the Gene Encoding the Major Surface Antigen ofToxoplasma gondiiJ. of Immunol., 141(10):3584-3591 (1988).
Carey, K.L., et al., “Identification and molecular characterization of GRA8, a novel, proline-rich, dense granule protein ofToxoplasma gondii”, Molec.&Biochem Parasitology, 105:25-37 (2000).
Cesbron-Delauw, M.F., et al., “Molecular characterization of a 23-kilodalton major antigen secreted byToxoplasma gondii”, Proc. Natl. Acad. Sci., USA, 86:7537-7541 (1989).
Chan, P.K.S., et al., “Antibody Avidity Maturation during Severe Acute Respiratory Syndrome-Associatd Coronavirus Infection”,J. Infect. Dis., 192:166-169 (2005).
Chee, M.S., et al., “Analysis of the Protein-Coding Content of the Sequence of Human Cytomegalovirus Strain LAD169”,Curr. Top. Microbiol. Immuno., 154:125-169 (1990).
Devash, Y., et al., “Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain”,Proc. Natl. Acad. Sci., USA, 87:3455-3449 (1990).
Devey, M.E., et al., “Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays”,J. of Immunol. Meth., 106:119-125 (1988).
De Souza, V.K.U.F., et al., “Use of an Immunoglobulin G Avidity Test To Discriminate between Primary and Secondary Dengue Virus Infections”,J. of Clin. Microbiol., 42(4):1782-1784 (2004).
Gassmann, C. & Bauer, G., “Avidity Determination of IgG Directed Against Tick-Borne Encephalitis Virus Improves Detection of Current Infections”,J. of Med. Virol., 51:242-251 (1997).
Gray, J.J. et al., “Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant virual VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity”,J. of Virol. Meth., 44:11-24 (1993).
Gutierrez F. J., et al., “Relaciórrez entrée el tiempo de evolución de la brcelosis humana y la avidez de anticuerpos IgG especificos”,Revista Medica de Chile, 123:819-822 (1995).
Halliday, G.M., et al., “Evaluation of an ELISA system for determination of class-specific antibodies to antive and denatured DNA in man”,Annals of the Rheumatic Dis., 44:507-513 (1985).
Hedman, K. & Seppala, I., “Recent Rubella Virus Infection Indicated by a Low Avidity of Specific IgG”,J. of Clin. Immunol., 8(3):214-221 (1988).
Hedman, K., et al., “Recent Primary Toxoplasma Infection Indicated by a Low Avidity of Specific IgG”,J. Infect. Dis., 159(4):736-740 (1989).
Hedman, K. & Rousseau S.A., “Measurement of Avidity of Specific IgG for Verification of Recent Primary Rubella”,J. of Med. Virol., 27:288-292 (1989).
Hedman, K., et al., “Rapid diagnosis of hantavirus disease with an IgG-avidity assay”,The Lancet, 338:1343-1356 (1991).
Inouye, S., et al., “Changes in Antibody Avidity After Virus Infections: Detection by an Immunosorbent Assay in Which a Mild Protein-Denaturing Agent Is Employed”,J. of Clin. Microbiol., 20*3):525-529 (1984).
Johnson, A.M. & Illana, S., “Cloning ofToxoplasma gondiigene fragments encoding diagnostic antigens”,Gene, 99:127-132 (1991).
Kaukonen, K., et al., “Avidity ofAspergillus umbrosusIgG antibodies in farmer's lung disease”,Clin. Exp. Immunol., 95:162-165 (1994).
Lappalainen, M., et al., “Toxoplasmosis Acquired during Pregnancy: Improved Serodiagnosis Based on Avidity of IgG”,J. Infect. Dis., 167:691-697 (1993).
Lazzarotto, T., et al., “Enzyme-Linked Immunoadsorbent Assay for the Detection of Cytomegalovirus IgM: Comparison Between Eight Commercial Kits, Immunofluorescence, and Immunoblotting”,J. of Clin. Lab. Analy., 6:216-218 (1992).
Lehner, R., et al., “Comparative Sequence Analysis of Human Cytomegalovirus Strains”,J. of Clin. Microbiol., 29(11):2494-2502 (1991).
Liesenfeld, O., et al., “False-Positive Results in Immunoglobulin M (IgM) Toxoplasma Antibody Tests and Importance of Confirmatory Testing: the Platelia Toxo IgM Test”,J. of Clin. Microbiol., 35(1):174-178 (1997).
Maine, G., et al., “New Developments in the diagnosis of maternal and congenital CMV infection”,Expert Rev. Mol. Diagn., 1(1):29-29 (2001).
Mevelec, M-N., et al., “Molecular cloning of GRA4, aToxoplasma gondiidense granule protein, recognized by mucosal IgA antibodies”,Molec.&biochem. Parasitol., 56:227-238 (1992).
Montoya, J.G., et al., “VIDAS Test for Avidity ofToxoplasma-Specific Immunoglobulin G for Confirmatory Testing of Pregnant Women”,J. of Clin. Microbiol., 40(7):2504-2508 (2002).
Morrow, R.A., et al., “Development and Use of a Type-Specific Antibody Avidity Test Based on Herpes Simplex Virus Type 2 Glycoprotein G”,Sexual. Transmitt. Dis., 31(8):508-515 (2004).
Mostafa, N.E., et al., “Low Avidity IGG Antibodies in Diagnosis of Recent Human Schistosimiasis”,J. of the Egyptian Soc. Of Parasitol., 32(3):979-985 (2002).
Naot, Y. & Remington, J.S., “An Enzyme-Linked Immunosorbent Assay for Detection of IgM Antibodies toToxoplasma gondii: Use for Diagnosis of Acute Acquired Toxoplasmosis”,J. of Inf. Dis., 142(5):757-766 (1980).
Nielsen, S.L., et al., “Kinetics of Specific Immunoglobulins M, E, A, and G in Congenital, Primary, and Secondary Cytomegalovirus Infection Studied
Christ Heike Maria
Curdt Ingo
Herzogenrath Jörg
Hsu Stephen C.
Maine Gregory T.
Abbott Laboratories
Bartnicki Audrey L.
Becker Cheryl L.
Mosher Mary R.
Snyder Stuart W.
LandOfFree
Methods for the determination of antibody IgG avidity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the determination of antibody IgG avidity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the determination of antibody IgG avidity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4001869